398 related articles for article (PubMed ID: 2013383)
21. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
Bansi D; Chapman R; Fleming K
J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
[TBL] [Abstract][Full Text] [Related]
22. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
Bansi DS; Fleming KA; Chapman RW
Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
[TBL] [Abstract][Full Text] [Related]
23. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Snook JA; Chapman RW; Fleming K; Jewell DP
Clin Exp Immunol; 1989 Apr; 76(1):30-3. PubMed ID: 2786779
[TBL] [Abstract][Full Text] [Related]
24. The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
Chapman RW
Hepatology; 1995 May; 21(5):1473-4. PubMed ID: 7737656
[No Abstract] [Full Text] [Related]
25. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
Tervaert JW; Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
Gastroenterology; 1992 Mar; 102(3):1090-1. PubMed ID: 1537508
[No Abstract] [Full Text] [Related]
26. The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
Mehal WZ; Lo SK; Chapman RW; Fleming KA
J Hepatol; 1994 Nov; 21(5):910-1. PubMed ID: 7890911
[No Abstract] [Full Text] [Related]
27. Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease.
Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
Adv Exp Med Biol; 1993; 336():545-9. PubMed ID: 8296673
[TBL] [Abstract][Full Text] [Related]
28. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis.
Winter HS; Landers CJ; Winkelstein A; Vidrich A; Targan SR
J Pediatr; 1994 Nov; 125(5 Pt 1):707-11. PubMed ID: 7965422
[TBL] [Abstract][Full Text] [Related]
29. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
Granito A; Zauli D; Muratori P; Muratori L; Grassi A; Bortolotti R; Petrolini N; Veronesi L; Gionchetti P; Bianchi FB; Volta U
Aliment Pharmacol Ther; 2005 Apr; 21(7):881-7. PubMed ID: 15801923
[TBL] [Abstract][Full Text] [Related]
30. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
31. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
[TBL] [Abstract][Full Text] [Related]
32. Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?
Lo SK; Chapman RW; Cheeseman P; Charlton CP; Walker-Smith JA; Mieli-Vergani G; Fleming KA
Gut; 1993 Feb; 34(2):199-202. PubMed ID: 8432473
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis.
Brimnes J; Nielsen OH; Wiik A; Heegaard NH
Dig Dis Sci; 1999 Feb; 44(2):415-23. PubMed ID: 10063932
[TBL] [Abstract][Full Text] [Related]
34. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
35. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.
Cambridge G; Rampton DS; Stevens TR; McCarthy DA; Kamm M; Leaker B
Gut; 1992 May; 33(5):668-74. PubMed ID: 1612485
[TBL] [Abstract][Full Text] [Related]
36. Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis.
Broomé U; Hultcrantz R; Lefvert AK; Yi Q
Dis Colon Rectum; 1998 Dec; 41(12):1543-9. PubMed ID: 9860336
[TBL] [Abstract][Full Text] [Related]
37. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil autoantibodies as disease markers for ulcerative colitis.
Shanahan F; Landers C; Duerr R; Targan SR
Immunol Res; 1991; 10(3-4):479-84. PubMed ID: 1955775
[No Abstract] [Full Text] [Related]
39. HLA antigens in ulcerative colitis and primary sclerosing cholangitis.
Leidenius MH; Koskimies SA; Kellokumpu IH; Höckerstedt KA
APMIS; 1995; 103(7-8):519-24. PubMed ID: 7576567
[TBL] [Abstract][Full Text] [Related]
40. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis.
Pokorny CS; Norton ID; McCaughan GW; Selby WS
J Gastroenterol Hepatol; 1994; 9(1):40-4. PubMed ID: 8155865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]